FDA Approves New Alzheimer’s Drug, But Not Without Controversy
source: pixabay.com

FDA Approves New Alzheimer’s Drug, But Not Without Controversy

According to an announcement from the US Food and Drug Administration (FDA), the agency has recently approved a new therapy for Alzheimer's disease. While this is a significant moment for…

Continue Reading FDA Approves New Alzheimer’s Drug, But Not Without Controversy
Parents of a Child With Familial Chylomicronemia Syndrome Advocate for Passing the HEART Act
source: pixabay.com

Parents of a Child With Familial Chylomicronemia Syndrome Advocate for Passing the HEART Act

According to an article in the Times Union, a group of parents with children who have been diagnosed with rare diseases are leading the crusade to foster federal legislation which…

Continue Reading Parents of a Child With Familial Chylomicronemia Syndrome Advocate for Passing the HEART Act

China Conditionally Approves Pamiparib for Those with Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer

BeiGene has just announced that China has given conditional approval to Pamiparib, a PARP inhibitor used as a therapy for BRCA associated ovarian cancer, fallopian tube cancer, and primary peritoneal…

Continue Reading China Conditionally Approves Pamiparib for Those with Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer
Cerebra Network for Neurodevelopmental Disorders: New Collaborative Research Network Investigates Rare Disorders
Sourced from publicdomainpictures.net (https://www.publicdomainpictures.net/en/view-image.php?image=275669&picture=chemical-research)

Cerebra Network for Neurodevelopmental Disorders: New Collaborative Research Network Investigates Rare Disorders

Rare disease research faces many obstacles: lack of participants, lack of funding, and lack of interest are just a few. Now, the charity Cerebra has launched a network to take…

Continue Reading Cerebra Network for Neurodevelopmental Disorders: New Collaborative Research Network Investigates Rare Disorders
The First Patient Has Been Dosed in a Trial for Glioblastoma, Medulloblastoma, and Ependymoma
source: pixabay.com

The First Patient Has Been Dosed in a Trial for Glioblastoma, Medulloblastoma, and Ependymoma

Mustang Bio, a biopharmaceutical company, and City of Hope, a cancer center, have just revealed that their first participant in their Phase 1 clinical trial for leptomeningeal brain tumors including…

Continue Reading The First Patient Has Been Dosed in a Trial for Glioblastoma, Medulloblastoma, and Ependymoma
Woman with Immune Thrombocytopenia and COVID-19 Successfully Gives Birth
source: pixabay.com

Woman with Immune Thrombocytopenia and COVID-19 Successfully Gives Birth

According to a story from republicworld.com, the medical fraternity of Queen Mary's Hospital in King George's Medical University, Lucknow was able to successfully treat a woman, age 35, with immune…

Continue Reading Woman with Immune Thrombocytopenia and COVID-19 Successfully Gives Birth
May is GBS and CIDP Awareness Month: Spreading Rare Disease Awareness
source: pixabay.com

May is GBS and CIDP Awareness Month: Spreading Rare Disease Awareness

The month of May is recognized as Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP) awareness month, a time set aside to spread awareness about these rare conditions among…

Continue Reading May is GBS and CIDP Awareness Month: Spreading Rare Disease Awareness